Showing results (31-40 of 481) with videos related to

Sort By:
Pageof 49
The American Journal of Cardiology|June 30, 2015
On-Statin Resistin, Leptin, and Risk of Recurrent Coronary Events After Hospitalization for an Acute Coronary Syndrome (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Study)Amit V Khera, Arman Qamar, Sabina A Murphy, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 12, 2002
Comparison of two different methods of quantitative coronary angiography in patients with acute coronary syndromesBoris V Sheynberg, Ik-Kyung Jang, Richard O Han, et al.
American Heart Journal|December 22, 2005
Combination of quantitative ST deviation and troponin elevation provides independent prognostic and therapeutic information in unstable angina and non-ST-elevation myocardial infarctionMarc S Sabatine, David A Morrow, Carolyn H McCabe, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|November 19, 2008
Validation of an automated safety surveillance system with prospective, randomized trial dataMichael E Matheny, David A Morrow, Lucila Ohno-Machado, et al.
Circulation|June 6, 2007
Long-term prognostic value of neopterin: a novel marker of monocyte activation in patients with acute coronary syndromeKausik K Ray, David A Morrow, Marc S Sabatine, et al.
Critical Pathways in Cardiology|March 11, 2010
Cost-effectiveness analysis of short-term clopidogrel therapy for ST elevation myocardial infarctionKyle B Gibler, Haiden A Huskamp, Marc S Sabatine, et al.
Journal of the American College of Cardiology|June 21, 2008
Thrombus precursor protein and clinical outcomes in patients with acute coronary syndromesJessica L Mega, David A Morrow, James A de Lemos, et al.
Circulation|March 16, 2006
Lipoprotein-associated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction) trialMichelle O'Donoghue, David A Morrow, Marc S Sabatine, et al.
JAMA Cardiology|January 26, 2017
Association Between Circulating Baseline Proprotein Convertase Subtilisin Kexin Type 9 Levels and Efficacy of EvolocumabNihar R Desai, Robert P Giugliano, Scott M Wasserman, et al.
European Heart Journal|March 19, 2008
Association between baseline neutrophil count, clopidogrel therapy, and clinical and angiographic outcomes in patients with ST-elevation myocardial infarction receiving fibrinolytic therapyMichelle O'Donoghue, David A Morrow, Christopher P Cannon, et al.
Pageof 49